Rheum2Learn: Inflammatory Myopathies: Key References

Skip to main content

Rheum2Learn: Inflammatory Myopathies

◄ Previous: Case Correlation to ACGME Core Competency Requirements Exit book ▲

Key References

Evaluation and treatment of inflammatory myopathies. Amato AA,Barohn RJ. J of Neurol Neurosurg & Psychiatry. 80(10):1060-1068, Oct 2009
Paraneoplastic myopathy.Danko K,Ponyi A, Molnar P,Andras C, Constantin T Curr Opin Rheum. 21(6):594-598, Nov 2009
Toxic and drug-induced myopathies.Dalakas M. J of Neurol Neurosurg & Psychiatry. 80(8):832-838, Aug 2009
Anti-synthetase syndrome: Not just an inflammatory myopathy. Chatterjee S, Prayson R, Farver C. Cleveland Clinic Journal of Medicine. 80(10):655-666, Oct 2013.
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin. Lee AJ,Maddix DS.Ann Pharmacother.2001 Jan; 35(1):26-31.
The muscular dystrophies.Wicklund MP.Continuum (Minneap Minn).2013 Dec;19 (6 Muscle Disease):1535-70.
Polymyositis-like syndrome in hypothyroidism: review of cases reported over the past twenty-five years.Madariaga MG.Thyroid.2002 Apr; 12(4):331-6.

◄ Previous: Case Correlation to ACGME Core Competency Requirements Exit book ▲

Skip Table of contents

Table of contents

Case 1
Case 2
Case Correlation to ACGME Core Competency Requirements
Key References

Skip Rheum2Learn: Inflammatory Myopathies Skip Rheum2Learn 2.0

Rheum2Learn 2.0

Fundamental rheumatology education designed for Residents.

Skip Rheum4Science

Rheum4Science

Immunology

Immunopathogenesis of Rheumatic Disease

Pathogenesis of Rheumatoid Arthritis

Clinical Research Methodology

Skip V-FIT Course

V-FIT Course

Virtual Rheumatology programs designed for Fellows in Training.